Correlation of Body Mass Index and Waist Hip Ratio with lipid and hormone profile in women in menopausal transition by Mešalić, Lejla
Lejla Mešaliæ Journal of Health Sciences 2014;4(1):12-18 http://www.jhsci.ba
Journal of Health Sciences 
© 2014 Lejla Mešaliæ; licensee University of Sarajevo - Faculty of Health Studies. This is an 
Open Access article distributed under the terms of the Creative Commons Attribution Li-
cense (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribu-
tion, and reproduction in any medium, provided the original work is properly cited.
UNIVERSITY OF SARAJEVO 
FACULTY OF HEALTH STUDIES
ABSTRACT
Introduction: Menopausal transition is a period characterised by psychic, somatic changes as well as 
changes in reproductive capabilities of a woman. It occurs as a consequence of ovarian’s function termina-
tion, and pertains to the periods of different meanings: perimenopause, menopause and postmenopause. 
Although there are numerous assessments of behaviour of the lipids and lipoproteins during menopausal 
transition, their relation to sexual hormones and body mass is still being assessed. The aim of this study is 
to determine the differences and connections between body mass index (BMI) and waist-hip ratio (WHR) 
and lipid and hormone profi le among the assessees in premenopause, perimenopause and postmeno-
pause.
Methods: The assessment was done on 150 assessees divided in three groups of 50, such as: premeno-
pause, perimenopause and postmenopause. The assessment included the following: interview, deter-
mination of BMI, WHR, and taking of blood sample and processing of hormone, lipid and lipoprotein 
concentration.
Results: Based on the obtained results, it may not be concluded that BMI has a positive correlation with 
cholesterol and VLDL concentration in postmenopause, positive correlation with apo A in perimenopause 
and postmenopause, and positive correlation with Lp (a) and apo B in premenopause and perimenopause, 
while negative correlation with HDL and estradiol concentrations in premenopause. WHR has negative 
correlation with HDL concentration in premenopause and perimenopause, and a negative correlation with 
estradiol concentrations in premenopause.
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INTRODUCTION
Menopausal transition is a period in life of a woman, 
with undefi ned beginning and duration, but with 
well-known changes in female organism. Meno-
pausal transition is a period characterized by psychic, 
somatic and reproductive changes of capabilities at 
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women (1). Hormonal profi le is changing during 
menopausal transition. Increased level of follicle-
stimulating hormone (FSH) stimulates follicles to 
grow, but those follicles mainly fail to reach the fi nal 
growth and maturity, which results with frequent 
anovulation. Progesterone production is 60 % lower 
than in reproduction period. In menopause, meta-
bolic changes occur in diff erent tissues and organs as 
a result of changed hormonal profi le (2). Fat tissue is 
not only a passive fat depot refl ecting the energy bal-
ance and thermo-regulation, but is also a signifi cant 
endocrine organ (3). Th e main source of estrogen in 
menopause is estron generated from androstendion 
in peripheral tissues. Conversion processes of andro-
gen to estrogens in menopause are not performed in 
fat tissue only, but also in central nervous system (4, 
5). One of the most important fat tissue hormones 
is leptin. During menopause, not only leptin, but 
also decreased level of growth hormone, E2 and an-
drogens lead to changes of lipogenesis and lipolysis 
mechanisms, which lead to characteristic distribu-
tion of fat tissue in menopause (centripetal obesity). 
Lipid profi le during menopausal transition changes, 
but all mechanisms of those changes are not clari-
fi ed. One of the most important factors in that 
mechanism is the change of fat tissue distribution 
in postmenopause. Total cholesterol level increases 
through menopausal transition, with highest values 
in menopause. LDLD increases during menopaus-
al transition, but it decreases after the menopause. 
Th e age is signifi cantly related to the changes in the 
triglyceride, total cholesterol and LDL level, while 
body mass index (BMI) is signifi cantly related to 
the changes of level of triglyceride, LDL, HDL (6). 
With menopause, HDL concentration decreases 
and HDL structure changes. HDL concentration 
is inversely proportional to abdominal obesity level 
(7). Menopause, age and increased distribution of 
abdominal fat tissue are three independent and 
important factors violating the lipoprotein profi le 
from the beginning of menopausal transition (8). 
Age, BMI and menopausal status are signifi cant in-
dicators of the circulating lipoprotein level during 
menopausal transition (9). BMI is used to calcu-
late the body surface and estimate the body weight. 
Doctors use BMI to estimate the risk of body weight 
and cardiac disease. New analysis of 40 studies, pub-
lished in the Lancet magazine (10), which includes 
250 000 patients, shows that the patients with BMI 
below 20 have higher mortality risk caused by car-
diovascular diseases than the obese patients with 
BMI 30-35. Th e assessees who smoke have some-
what lower total cholesterol and signifi cantly lower 
HDL, although there is no diff erence in BMI distri-
bution between the assessees who smoke and those 
who do not (11). E2 level is much lower at the obese, 
premenopausal women than at the premenopausal 
women of normal body weight. FSH level is also 
lower at the obese postmenopausal women than at 
the non-obese postmenopausal women (12). BMI 
impact to E2 and FSH varies in dependence on 
menopausal profi le (13). Waist-hip ratio, WHR is 
statistically important predictor of LDL concentra-
tion and cholesterol in relation to BMI at women in 
menopause, which confi rms the importance of fat 
tissue distribution as a risk factor for cardiovascular 
diseases at this group of women (14). Sultan and 
associates (15) state that waist-hip ratio may be used 
as screening for identifi cation of postmenopausal 
women with higher cardiovascular risk. 
Th e aim of this study was to determine the diff er-
ences and connection of BMI and WHR with lipid 
and hormonal profi le of women in premenopause, 
perimenopause and postmenopause.
METHODS
Th is prospective, comparative study was conducted 
in period November 2009 – December 2010 and it 
included a total of 150 assessees aged 40-55, divided 
into three groups of 50 assessees each (premeno-
pause, perimenopause and postmenopause). Th e 
assessees comprised women volunteers who agreed 
in writing to be included in the study. Each assess-
ee was introduced with the character of the study 
implemented according to the generally accepted 
ethical standards for medical research. Qualifi ca-
tion criteria for inclusion into the study were: that 
the candidates do not take hormonal supplemen-
tal therapy, that they do not take medicines which 
could aff ect the lipid profi le, that they do not con-
sume more than twenty cigarettes a day, that their 
BMI does not exceed 35kg/m². Processing of assess-
ees comprised three phases: interview, taking blood 
sample, measuring BMI and WHR. For the purpose 
of analysis, the vein blood sample from cubital vein 
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was taken, after which the blood was centrifuged, 
and obtained serum divided into two test tubes. Th e 
same day, concentration of lipid, lipoprotein, FSH, 
LH and E2 was determined. Concentration of the 
total cholesterol, triglyceride, LDL, HDL, VLDL, 
apo A, apo B and Lp (a) was also determined. To-
tal cholesterol and triglyceride concentration was 
determined using enzymatic method at SIEMENS 
«Dimension RxL» machine. HDL and LDL were 
determined at the same machine utilizing direct 
„homogenous“ method. VLDL was calculated with 
formula: VLDL = total cholesterol - HDL – LDL 
apo A, apo B and Lp (a) values were determined 
using immunoturbidimetry method at SIEMENS 
«Dimension RxL» machine, and reagents of the 
company „SENTINEL“ were used. FSH, LH and 
E2 values were determined utilizing the hemilumi-
niscence method. Th e assessees' body weight and 
height were measured at the „SECA“scale with me-
ter. Fattening status was assessed based on the Qeue-
telet index (Devenport-Kaup modifi cation) or BMI 
where: BMI= body mass in kg/height in m². Based 
on the waist measuring at the narrowest place and 
hip measuring at the widest place, WHR was calcu-
lated according to the following formula: WH ratio 
= waist (cm)/hip (cm).
Statistical analysis
To compare the numerical variables among the as-
sesse groups we used the variance analysis (ANO-
VA) or Kruskal-Wallis non-parametric alternative. 
To analyse relation of BMI, WHR, menarche and 
reproductive age factors with lipid and hormonal 
profi le, we used linear regression model. Each factor 
was tested in bivariate model, adjusted to the group 
of assessees. Results are presented at regression co-
effi  cient with related 95% reliability interval (IP). 
Statistical signifi cance was confi rmed at p<0.05. 
Statistic programme PASW 18 (SPSS Inc., Chicago, 
Illinois, USA) was used for data processing.
RESULTS 
Th e assessees included in the study were aged 40 to 
55, with average age 48.1 ± 3.9. Statistically, the age 
between the groups diff ered signifi cantly: the as-
sessees in perimenopause were 2 years older in aver-
age than those in premenopause (95% IP: 0.6-3.5 
years), and the assessees in postmenopause were four 
years older in average than those in perimenopause 
(95% IP: 2.6-5.4 years) (Table 1). In addition, the 
assessees from the second group had somewhat low-
er WHR than the assessees from the third group, al-
though the diff erence was not statistically signifi cant 
(average diff erence = 0.03, 95% IP: -0.003-0.06). 
Th ere is a signifi cant negative relation between BMI 
and HDL at assessees in premenopause (Table 2). 
If the regression coeffi  cient had been standardised 
to interquartile value of BMI change (IQR=5), the 
diff erence of 0.18 mmol/L in medium HDL con-
centration between low and high BMI would have 
been suggested. Among the assessees in postmeno-
pause, there is a signifi cant relation between BMI 
and cholesterol, as well as between BMI and VLDL. 
For interquartile value of BMI change, standard 
regression coeffi  cient shows the increase of 0.67 
mmol/L in medium cholesterol concentration and 
increase of 0.22 mmol/L in medium VLDL con-
centration. Th ere are no proofs of any relation be-
tween other lipid and BMI parameters. Multivariate 
regression analysis showed that the only important 
lipid fraction aff ected by BMI is HDL cholesterol. 
Considering the BMI value in relation to apo A, 
results indicate that there is a correlation between 
the groups of assessees in perimenopause and post-
Group I 
 (n=50)
Group I 
(n=50)
Group III 
 (n=50) P value
Age 45.4 ± 3.2 (40-52)
47.4 ± 2.6 
(41-52)
51.4 ± 3.2 
(43-55) <0.001
Menarche, 
age
14.2 ± 1.6 
(11-18)
13.8 ± 2.0 
(10-18)
14.1 ± 1.7 
(11-17) 0.574
Age at last 
menstruation -
47.2 ± 2.5 
(41-52)
47.9 ± 3.3 
(39-54) 0.262
Reproductive 
age -
33.4 ± 2.7 
(26-39)
33.8 
(26-42) 0.570
BMI (kg/m2) 26.3 ± 3.7 (20.0-36.0)
26.4 ± 3.8 
(18.5-37.0)
26.9 ± 3.4 
(22.0-36.0) 0.640
WHR 0.81 ± 0.05 (0.70-0.97)
0.79 ± 
0.08 
(0.43-0.90)
0.81 ± 
0.06 
(0.67-0.90)
0.076
TABLE 1.  Main features of assessees1 
1Values are arithmetic median value ± SD as well as minimum 
and maximum. Group I= assessees in premenopause; group II= 
assessees in perimenopause; group III= assessees in postmeno-
pause.
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menopause according to the fi rst signifi cance order 
(p<0.001), while between the assessees in premeno-
pause and postmenopause there is no signifi cant 
diff erence (p=0.516). Correlating BMI value in 
relation to apo B, there was statistically signifi cant 
diff erence between the assessees in perimenopause 
and premenopause (p=0.003), while between the as-
sessees in postmenopause and premenopause there 
was no statistically signifi cant diff erence (p=0.367). 
Obtained results regarding Lp (a) indicate the sig-
nifi cant correlation in relation to BMI, only among 
the asssessees in postmenopause and premenopause 
(p<0.001). Of three analysed hormones, signifi cant 
relation with BMI is noted only for E2 at women 
in premenopause (Table 3). For increase of unit in 
BMI, regression coeffi  cient suggests 8.9-pecent de-
crease in medium E2 concentration. Th ere is a sig-
nifi cant negative relation between WHR and HDL 
at the assessees in premenopause and perimeno-
pause (Table 4). At WHR change of 0.05, regres-
sion coeffi  cient shows the diff erence of 0.11 mmol/L 
in medium HDL concentration at the assessees in 
premenopause, and the diff erence of 0.09 mmol/L 
in medium HDL concentration at the assessees in 
perimenopause. Th e only signifi cant relation be-
tween WHR and hormone parameters is proven for 
E2 at the assessees in premenopause (Table 5). Me-
dium estradiol concentration decreased 1.29 times 
at WHR increase for 0.05.
DISCUSSION
Numerous studies addressed the issue of lipid chang-
es during menopausal transition or related to meno-
pausal changes of endogenous hormones. Although 
the numerous researches have been done on behav-
iour of lipids and lipoprotein during menopausal 
transition, their relation with sexual hormones and 
body mass is still being assessed. Th e average age in 
time of the last menstruation among the assessees 
included in this study is 48. One of the objectives of 
this study was to determine the relation of BMI and 
WHR with lipid and hormonal profi le of assessees 
in menopausal transition, and the results show that 
at the assessees in postmenopause, there is a posi-
tive correlation between BMI and total cholesterol, 
and BMI and VLDL cholesterol, and negative cor-
relation between BMI and HDL in premenopause. 
Th ere are no proofs of any relation between other lip-
id and BMI parameters. Other studies also indicate 
that women with higher BMI are exposed to the risk 
of higher lipid level, although skinner women can 
also have higher hormone-related LDL cholesterol 
during menopausal transition (16). Duration of 
postmenopause, as well as BMI in similar studies do 
not show signifi cant correlation with lipid, lipopro-
tein and Lp (a) concentration, while WHR shows 
signifi cant positive correlation with cholesterol, 
LDL and apo B (14) concentrations. According to 
Yamamoto and associates (11), there is no signifi cant 
correlation between BMI and serum Lp (a) value, 
and medium Lp (a) value shows the possible trend 
of increase at women over 40. Th is study showed 
signifi cant correlation between BMI and Lp (a) at 
the assessees in postmenopause and premenopause, 
which is confi rmed by contemporary knowledge on 
impact of higher Lp (a) to the increase of cardio-
vascular risk. We determined a signifi cant negative 
relation between WHR and HDL cholesterol at 
the assesses in premenopause and perimenopause, 
while in relation to other lipids, there were no cor-
relations. According to Mešalić (14), among women 
in premenopause, WHR has a signifi cant negative 
correlation with HDL and Apo lipoprotein A con-
centration, which, considering the role of these two 
lipoproteins in occurrence of cardiovascular diseases, 
confi rms that even women with regular menstrua-
tions and higher WHR have the risk of cardiovas-
cular diseases. Results of this study indicate nega-
tive correlation between WHR and estradiol at the 
assesses in premenopause and negative correlation 
between BMI and estradiol in premenopause. How-
ever, with increase of WHR and BMI, the estrogen 
level decreases in premenopause, based on which 
the women with higher cardiovascular risk may be 
identifi ed. Assessment results of the comprehensive 
study conducted by the National Health and Nutri-
tion Examination Survey among the assessees aged 
35-60 in period 1999-2002 (17) show that there are 
no signifi cant diff erences in total cholesterol, tri-
glyceride, HDL, LDL cholesterol levels adjusted to 
the age, among menopausal periods at the group of 
women with normal BMI. Th e diff erence in HDL 
cholesterol values was noticed at the groups with 
normal and higher BMI. In the groups of assessees 
with normal BMI, LH and FSH hormones activ-
18
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ity was statistically diff erent than at the assessees in 
premenopause and perimenopause, and between 
the assessees in premenopause and postmenopause 
(17). SO, according to Azizi and Ainy (18) BMI, 
WHR and triglyceride value in blood does not show 
the signifi cant diff erences between the assessees in 
premenopause, perimenopause and postmenopause. 
Despite numerous studies, physiological role of Lp 
(a) has not been determined. Its atrogenous infl u-
ence is attributed to enormous similarity of Lp(a) 
and LDL in structure, which are very cholesterol 
rich. In this study, Lp (a) was the highest at the as-
sessees in premenopause and postmenopause. Some-
what diff erent results are presented by Kim and as-
sociates (19), who obtained lower Lp (a) values at 
perimenopausal assessees than at postmenopausal 
assessees.
CONCLUSION 
BMI has a positive correlation with cholesterol con-
centration and VLDLD in postmenopause, positive 
correlation with apo A in perimenopause and post-
menopause, and positive correlation with Lp (a) and 
apo B in premenopause and perimenopause, while 
with HDL and estradiol concentration it has a nega-
tive correlation in premenopause.
WHR has negative correlation with HDL concen-
tration in premenopause and perimenopause, and 
negative correlation with estradiol concentrations 
in premenopause. However, with increase of WHR 
and BMI, the estrogen level in premenopause de-
creases, based on which the women with higher 
cardio-vascular risks may be identifi ed. 
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